Emergent BioSolutions(EBS) - 2024 Q2 - Quarterly Results

EMERGENT BIOSOLUTIONS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS • Second Quarter 2024 Total Revenues of $254.7 million, above the prior guidance range • Second Quarter 2024 Net Loss of $283.1 million and Adjusted EBITDA of $(10.1) million • Updates FY 2024 guidance GAITHERSBURG, Md., August 6, 2024—Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second quarter ended June 30, 2024. "In the first half of the year, we made great progress to stabilize our financial position b ...